Advances in Chronic Kidney Disease
Volume 15, Issue 1 , Pages 19-28, January 2008

Disease Management in Chronic Kidney Disease

  • Anjay Rastogi
  • ,
  • Ariel Linden
  • ,
  • Allen R. Nissenson

      Affiliations

    • Corresponding Author InformationAddress correspondence to Allen R. Nissenson, MD, FACP, David Geffen School of Medicine at UCLA, Department of Medicine, Division of Nephrology, Box 951689, 7-155 Factor Bldg, Los Angeles, CA 90095-1689.

David Geffen School of Medicine at UCLA, Los Angeles, CA; Linden Consulting Group, Portland, OR; and Oregon Health and Science University, Joint Faculty, School of Medicine and School of Nursing, Portland, OR

Chronic kidney disease (CKD) is a growing health problem of epidemic proportions both in the United States and worldwide. The care of CKD patients, before and after starting dialysis, remains highly fragmented resulting in suboptimal clinical outcomes and high costs, creating a high burden of disease on patients and the health care system. Disease management (DM) is an approach to coordinating care for this complex population of patients that has the promise of improving outcomes and constraining costs. For CKD patients not yet on dialysis, the major goals of a DM program are (1) early identification of CKD patients and therapy to slow the progression of CKD, (2) identification and management of the complications of CKD per se, (3) identification and management of the complications of comorbid conditions, and (4) smooth transition to renal replacement therapy. For those CKD patients on dialysis, focused attention on avoidable hospitalizations is a key to a successful DM program. Multidisciplinary collaboration among physicians (nephrologist, primary care physician, cardiologist, endocrinologist, vascular surgeons, and transplant physicians) and participating caregivers (nurse, pharmacist, social worker, and dietician) is critical as well. There are several potential barriers to the successful implementation of a CKD/end-stage renal disease DM program, including lack of awareness of the disease state among patients and health care providers, late identification and referrals to a nephrologist, complex fragmented care delivered by multiple providers in many different sites of care, and reimbursement that does not align incentives for all involved. Recent experience suggests that these barriers can be overcome, with DM becoming a promising approach for improving outcomes for this vulnerable population.

Index Words: Chronic kidney disease, End-stage renal disease, Disease management, Disease management organization, Medicare

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Nissenson is supported in part by the Richard Rosenthal Dialysis Fund.

PII: S1548-5595(07)00150-4

doi:10.1053/j.ackd.2007.10.011

Advances in Chronic Kidney Disease
Volume 15, Issue 1 , Pages 19-28, January 2008